These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 22545968)

  • 1. A comparison of neuroprotective efficacy of the oxime K203 and its fluorinated analogue (KR-22836) with obidoxime in Tabun-poisoned rats.
    Kassa J; Karasova JZ; Tesarova S; Musilek K; Kuca K; Jung YS
    Basic Clin Pharmacol Toxicol; 2010 Nov; 107(5):861-7. PubMed ID: 22545968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the potency of newly developed oximes (K074, K075) and commonly used oximes (obidoxime, HI-6) to counteract tabun-induced neurotoxicity in rats.
    Kassa J; Karasova J
    Toxicology; 2007 Jan; 229(1-2):136-44. PubMed ID: 17141392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An evaluation of therapeutic and reactivating effects of newly developed oximes (K156, K203) and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
    Kassa J; Karasova J; Musilek K; Kuca K
    Toxicology; 2008 Jan; 243(3):311-6. PubMed ID: 18054821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the potency of newly developed oximes (K027, K048) and commonly used oximes (obidoxime, HI-6) to counteract tabun-induced neurotoxicity in rats.
    Kassa J; Kunesova G
    J Appl Toxicol; 2006; 26(4):309-16. PubMed ID: 16552727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of neuroprotective efficacy of newly developed oximes (K203, K206) and commonly used oximes (obidoxime, HI-6) in tabun-poisoned rats.
    Kassa J; Karasova J; Vasina L; Bajgar J; Kuca K; Musilek K
    Drug Chem Toxicol; 2009; 32(2):128-38. PubMed ID: 19514949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the potency of two novel bispyridinium oximes (K456, K458) in comparison with oxime K203 and trimedoxime to counteract tabun-induced neurotoxicity in rats.
    Kassa J; Misik J; Karasova JZ
    Basic Clin Pharmacol Toxicol; 2013 Sep; 113(3):201-8. PubMed ID: 23647829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of neuroprotective efficacy of two novel reactivators of acetylcholinesterase called K920 and K923 with the oxime K203 and trimedoxime in tabun-poisoned rats.
    Kassa J; Misik J; Hatlapatkova J; Zdarova Karasova J
    Toxicol Mech Methods; 2017 Mar; 27(3):236-243. PubMed ID: 28043192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The benefit of combination of oximes for the neuroprotective efficacy of antidotal treatment of sarin-poisoned rats.
    Kassa J; Kunesova G
    Toxicol Mech Methods; 2012 May; 22(4):260-7. PubMed ID: 22149934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the potency of a novel bispyridinium oxime K203 and currently available oximes (obidoxime, HI-6) to counteract the acute neurotoxicity of sarin in rats.
    Kassa J; Misik J; Karasova JZ
    Basic Clin Pharmacol Toxicol; 2012 Nov; 111(5):333-8. PubMed ID: 22536919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the neuroprotective efficacy of individual oxime (HI-6) and combinations of oximes (HI-6+trimedoxime, HI-6+K203) in soman-poisoned rats.
    Kassa J; Karasova JZ; Tesarova S
    Drug Chem Toxicol; 2011 Jul; 34(3):233-9. PubMed ID: 21649476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of reactivating and therapeutic efficacy of bispyridinium acetylcholinesterase reactivator KR-22934 with the oxime K203 and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
    Kassa J; Karasova JZ; Pavlikova R; Musilek K; Kuca K; Bajgar J; Jung YS
    Toxicol Mech Methods; 2011 Mar; 21(3):241-5. PubMed ID: 21142778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of reactivating and therapeutic efficacy of the oxime K203 and its fluorinated analog (KR-22836) with currently available oximes (obidoxime, trimedoxime, HI-6) against tabun in rats and mice.
    Kassa J; Karasova JZ; Caisberger F; Musilek K; Kuca K; Jung YS
    J Enzyme Inhib Med Chem; 2010 Aug; 25(4):480-4. PubMed ID: 20233085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evaluation of the neuroprotective effects of bispyridinium oximes in tabun-poisoned rats.
    Kassa J; Karasova J
    J Toxicol Environ Health A; 2007 Sep; 70(18):1556-67. PubMed ID: 17710615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Evaluation of the Reactivating and Neuroprotective Efficacy of Two Newly Prepared Bispyridinium Oximes (K305, K307) in Tabun-Poisoned Rats-A Comparison with Trimedoxime and the Oxime K203.
    Kassa J; Misik J; Hatlapatkova J; Zdarova Karasova J; Sepsova V; Caisberger F; Pejchal J
    Molecules; 2017 Jul; 22(7):. PubMed ID: 28696367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of combinations of oximes on the reactivating and therapeutic efficacy of antidotal treatment of tabun poisoning in rats and mice.
    Kassa J; Karasova JZ; Pavlikova R; Misik J; Caisberger F; Bajgar J
    J Appl Toxicol; 2010 Mar; 30(2):120-4. PubMed ID: 19746406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the ability of newly-developed bispyridinium oxime K203 and currently available oximes (trimedoxime, obidoxime, HI-6) to counteract the acute neurotoxicity of soman in rats.
    Kassa J; Karasova JZ; Tesarova S; Kuca K; Musilek K
    Toxicol Mech Methods; 2010 Oct; 20(8):445-51. PubMed ID: 20738156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective effects of currently used antidotes in tabun-poisoned rats.
    Kassa J; Krejèová G
    Pharmacol Toxicol; 2003 Jun; 92(6):258-64. PubMed ID: 12787257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined approach to demonstrate acetylcholinesterase activity changes in the rat brain following tabun intoxication and its treatment.
    Bajgar J; Hajek P; Kassa J; Slizova D; Krs O; Karasova JZ; Fusek J; Capek L; Voicu VA
    Toxicol Mech Methods; 2012 Jan; 22(1):60-6. PubMed ID: 21851296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evaluation of neuroprotective efficacy of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) in cyclosarin-poisoned rats.
    Kassa J; Karasova J; Vasina L
    J Appl Toxicol; 2007; 27(6):621-30. PubMed ID: 17685413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the potency of newly developed oximes (K347, K628) and currently available oximes (obidoxime, HI-6) to counteract acute neurotoxic effects of Tabun in rats.
    Kassa J; Karasová JZ; Tesarová S; Musílek K; Kuca K
    Acta Medica (Hradec Kralove); 2010; 53(2):85-91. PubMed ID: 20672744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.